REGISTERED NUMBER: 07932878 (England and Wales)

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

4T MEDICAL LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

J T Tordjmann

L R E Tordjmann

REGISTERED OFFICE:

Unit 10F Bourn Quarter

Wellington Way

Caldecote

Cambridge

Cambridgeshire

CB23 7FW

REGISTERED NUMBER:

07932878 (England and Wales)

ACCOUNTANTS:

Thompson Taraz Rand Ltd

Chartered Accountants

10 Jesus Lane

Cambridge

Cambridgeshire

CB5 8BA

FIXED ASSETS

Intangible assets

5

24,270

30,849

Tangible assets

6

477,187

405,715

501,457

436,564

CURRENT ASSETS

Stocks

729,419

707,794

Debtors

7

287,894

475,882

Cash and cash equivalents

3,257,578

2,139,509

4,274,891

3,323,185

CREDITORS

Amounts falling due within one year

8

(940,314

)

(711,829

)

NET CURRENT ASSETS

3,334,577

2,611,356

TOTAL ASSETS LESS CURRENT LIABILITIES

3,836,034

3,047,920

PROVISIONS FOR LIABILITIES

9

(89,713

)

(64,499

)

NET ASSETS

3,746,321

2,983,421

CAPITAL AND RESERVES

Called up share capital

10

2

2

Retained earnings

3,746,319

2,983,419

SHAREHOLDERS' FUNDS

3,746,321

2,983,421

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 September 2025 and were signed on its behalf by:

J T Tordjmann - Director

1.	STATUTORY INFORMATION

4T Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty

Useful economic lives of tangible fixed assets:

Tangible fixed assets are depreciated over their expected useful lives taking into consideration residual values, where appropriate. The actual lives of the assets and residual values are assessed and amended when necessary to reflect the current estimates based on economic utilisation and physical condition of the assets.

Doubtful debts:

The company makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade debtors , management considers factors including the current credit rating of the debtor, the ageing of the debtor and historical experience regarding payment history.

Turnover

Turnover represents the sale of skincare products and is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Revenue is recognised in the profit and loss account when a sales invoice is raised and this occurs on the dispatch of goods.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Leasehold Improvements

20% on cost

Plant and Machinery

25% on cost

Fixtures and Fittings

25% on cost

Motor vehicles

25% on cost

Computer equipment

25% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments

Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all material timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 33 (2023 - 21 ) .

5.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

£

COST

At 1 January 2024

and 31 December 2024

65,791

AMORTISATION

At 1 January 2024

34,942

Charge for year

6,579

At 31 December 2024

41,521

NET BOOK VALUE

At 31 December 2024

24,270

At 31 December 2023

30,849

Other intangible fixed assets relate to computer software.

6.	TANGIBLE FIXED ASSETS

Fixtures

Short

Plant and

and

leasehold

machinery

fittings

£

£

£

COST

At 1 January 2024

385,718

9,434

100,865

Additions

-

-

154,139

At 31 December 2024

385,718

9,434

255,004

DEPRECIATION

At 1 January 2024

26,438

4,914

73,081

Charge for year

36,828

2,358

39,165

At 31 December 2024

63,266

7,272

112,246

NET BOOK VALUE

At 31 December 2024

322,452

2,162

142,758

At 31 December 2023

359,280

4,520

27,784

Motor

Computer

vehicles

equipment

Totals

£

£

£

COST

At 1 January 2024

8,250

61,445

565,712

Additions

-

2,718

156,857

At 31 December 2024

8,250

64,163

722,569

DEPRECIATION

At 1 January 2024

8,250

47,314

159,997

Charge for year

-

7,034

85,385

At 31 December 2024

8,250

54,348

245,382

NET BOOK VALUE

At 31 December 2024

-

9,815

477,187

At 31 December 2023

-

14,131

405,715

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade debtors

250,379

233,509

Other debtors

37,515

242,373

287,894

475,882

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade creditors

144,383

118,796

Taxation and social security

728,031

481,582

Other creditors

67,900

111,451

940,314

711,829

9.	PROVISIONS FOR LIABILITIES

2024

2023

£

£

Deferred tax

89,713

64,499

Deferred

tax

£

Balance at 1 January 2024

64,499

Provided during year

25,214

Effect of rate movement

Balance at 31 December 2024

89,713

Deferred tax is recognised in respect of the excess of capital allowances over depreciation.

10.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2024

2023

value:

£

£

2

Ordinary

£1

2

2

11.	OTHER FINANCIAL COMMITMENTS

At the balance sheet date the company had off balance sheet commitments due under non cancellable operating leases amounting to £493,062 (2023: £612,536) in respect of the leasing of commercial units and company vehicles.

12.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2024 and 31 December 2023:

2024

2023

£

£

J T Tordjmann and L R E Tordjmann

Balance outstanding at start of year

203,000

162,531

Amounts advanced

7,713

221,735

Amounts repaid

(210,713

)

(181,266

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

-

203,000

Included within Amounts Advanced is beneficial loan interest charged at 2.25% of £4,604 (2023 £3,000). It is expected these advances will be repaid in full within nine months of the balance sheet date,

13.	RELATED PARTY DISCLOSURES

During the year under review £7,713 (2023: £221,736) was advanced to the directors. These advances are unsecured and repayable on demand. Total advances includes beneficial loan interest charged at 2.25% of £4,604 (2023:£3,857).The amount due the directors at the balance sheet date following repayment by way of interim dividend is £327 (2023: £203,000 DR) and included within other creditors.